SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-122962
Filing Date
2023-04-28
Accepted
2023-04-27 19:02:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d415282ddefa14a.htm DEFA14A 11151
2 GRAPHIC g415282dsp002.jpg GRAPHIC 176120
3 GRAPHIC g415282dsp003.jpg GRAPHIC 56590
  Complete submission text file 0001193125-23-122962.txt   322164
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40551 | Film No.: 23859346
SIC: 2836 Biological Products, (No Diagnostic Substances)